Pulsetto Vagus Nerve Stimulator Gains Attention in 2026

Got story updates? Submit your updates here. ›

A 2026 informational overview of publicly available details covering the Pulsetto transcutaneous vagus nerve stimulator (tVNS), including its Lite and FIT variants, companion app features, neck-worn wearable design, FCC certification status, pricing context, contraindications, and consumer wellness device use considerations — based on publicly available product information and not a clinical assessment or medical recommendation.

Why it matters

Interest in non-invasive wellness technologies has increased in 2026, particularly in categories focused on stress management and sleep support. Within that broader space, vagus nerve stimulation devices have become one of the more widely searched consumer wearable categories, and Pulsetto is one of several brands appearing in this category.

The details

Pulsetto is a neck-worn consumer electronics device produced by UAB Pulsetto, a company based in Vilnius, Lithuania. Publicly available documentation indicates that the device delivers low-level electrical signals and is designed to be used alongside relaxation practices. Product information describes a companion app that guides short sessions. Pulsetto is presented in consumer-facing materials as a wellness device rather than a treatment for medical conditions. It is FCC-certified, which reflects compliance with consumer electronics standards for radio-frequency equipment sold in the United States.

• Pulsetto was introduced to the market in 2026.

What’s next

Readers can view the current Pulsetto offer (official Pulsetto page) for the latest product details, pricing, and policy information directly from the source.